Chinese Drug Companies Expected To Outperform Device Makers In 2010 - Morgan Stanley Valuation Overview
This article was originally published in PharmAsia News
SHANGHAI - With a strong IPO performance for the Chinese healthcare sector in 2009, the total market cap for Chinese healthcare companies has reached $145 billion with 185 companies listed globally, according to the first China Healthcare Valuation Map, developed by Morgan Stanley research group in Hong Kong
You may also be interested in...
SHANGHAI - Backed by Beijing's $124 billion investment in health system reforms over the next several years, the entire healthcare industry in China will see strong growth in 2010, say analysts from Morgan Stanley's research department
HONG KONG - Concerns over valuation seem to be doing little to dampen enthusiasm for new Chinese pharmaceutical related stocks and the result is a minefield of opportunities on very shaky ground
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).